News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
871,858 Results
Type
Article (88100)
Company Profile (825)
Press Release (782913)
Multimedia
Podcasts (202)
Webinars (29)
Section
Business (233321)
Career Advice (4150)
Deals (39888)
Drug Delivery (151)
Drug Development (91458)
Employer Resources (205)
FDA (18417)
Job Trends (17435)
News (398047)
Policy (39983)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3019)
Academic (2)
Accelerated approval (37)
Adcomms (36)
Allergies (154)
Alliances (56982)
ALS (184)
Alzheimer's disease (1816)
Antibody-drug conjugate (ADC) (361)
Approvals (18607)
Artificial intelligence (654)
Autoimmune disease (184)
Automation (43)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (209)
Biotechnology (490)
Bladder cancer (166)
Brain cancer (67)
Breast cancer (682)
Cancer (5184)
Cardiovascular disease (460)
Career advice (3574)
Career pathing (42)
CAR-T (315)
CDC (63)
Celiac Disease (2)
Cell therapy (862)
Cervical cancer (38)
Clinical research (77224)
Collaboration (1891)
Company closure (5)
Compensation (1210)
Complete response letters (78)
COVID-19 (2999)
CRISPR (105)
C-suite (931)
Cystic fibrosis (155)
Data (6465)
Decentralized trials (2)
Denatured (74)
Depression (158)
Diabetes (545)
Diagnostics (7277)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (320)
Drug pricing (227)
Drug shortages (36)
Duchenne muscular dystrophy (249)
Earnings (100448)
Editorial (67)
Employer branding (25)
Employer resources (174)
Events (135421)
Executive appointments (1057)
FDA (21706)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1601)
Gene editing (225)
Generative AI (70)
Gene therapy (694)
GLP-1 (1147)
Government (5467)
Grass and pollen (8)
Guidances (388)
Healthcare (20966)
HIV (70)
Huntington's disease (51)
IgA nephropathy (88)
Immunology and inflammation (307)
Immuno-oncology (66)
Indications (116)
Infectious disease (3306)
Inflammatory bowel disease (212)
Inflation Reduction Act (17)
Influenza (129)
Intellectual property (264)
Interviews (816)
IPO (17967)
IRA (61)
Job creations (5201)
Job search strategy (2867)
JPM (71)
Kidney cancer (18)
Labor market (97)
Layoffs (662)
Leadership (42)
Legal (10165)
Liver cancer (99)
Longevity (16)
Lung cancer (700)
Lymphoma (390)
Machine learning (45)
Management (66)
Manufacturing (894)
MASH (179)
Medical device (15069)
Medtech (15128)
Mergers & acquisitions (23018)
Metabolic disorders (1443)
Multiple sclerosis (173)
NASH (23)
Neurodegenerative disease (371)
Neuropsychiatric disorders (106)
Neuroscience (3190)
Neurotech (1)
NextGen: Class of 2026 (7709)
Non-profit (5120)
Now hiring (68)
Obesity (703)
Opinion (341)
Ovarian cancer (172)
Pain (219)
Pancreatic cancer (242)
Parkinson's disease (306)
Partnered (39)
Patents (534)
Patient recruitment (520)
Peanut (61)
People (67054)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23860)
Phase 2 (33510)
Phase 3 (25240)
Pipeline (5572)
Policy (346)
Postmarket research (3554)
Preclinical (10707)
Press Release (72)
Prostate cancer (255)
Psychedelics (60)
Radiopharmaceuticals (309)
Rare diseases (957)
Real estate (7443)
Recruiting (81)
Regulatory (29214)
Reports (69)
Research institute (2737)
Resumes & cover letters (652)
Rett syndrome (28)
RNA editing (21)
RSV (88)
Schizophrenia (162)
Series A (265)
Series B (204)
Service/supplier (30)
Sickle cell disease (106)
Special edition (28)
Spinal muscular atrophy (178)
Sponsored (49)
Startups (4337)
State (2)
Stomach cancer (20)
Supply chain (115)
Tariffs (101)
The Weekly (126)
Vaccines (1183)
Venture capital (101)
Weight loss (483)
Women's health (97)
Worklife (22)
Date
Today (218)
Last 7 days (686)
Last 30 days (2533)
Last 365 days (32904)
2026 (4170)
2025 (33229)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (92)
Alaska (7)
Arizona (348)
Arkansas (14)
Asia (51641)
Australia (9071)
California (11872)
Canada (3407)
China (1205)
Colorado (503)
Connecticut (518)
Delaware (358)
Europe (118720)
Florida (1758)
Georgia (381)
Hawaii (4)
Idaho (68)
Illinois (990)
India (75)
Indiana (559)
Iowa (24)
Japan (451)
Kansas (135)
Kentucky (44)
Louisiana (30)
Maine (84)
Maryland (1482)
Massachusetts (8714)
Michigan (371)
Minnesota (677)
Mississippi (6)
Missouri (143)
Montana (36)
Nebraska (29)
Nevada (128)
New Hampshire (86)
New Jersey (3184)
New Mexico (33)
New York (3137)
North Carolina (1654)
North Dakota (10)
Northern California (5715)
Ohio (364)
Oklahoma (23)
Oregon (55)
Pennsylvania (2367)
Puerto Rico (25)
Rhode Island (51)
South America (1665)
South Carolina (68)
South Dakota (1)
Southern California (4590)
Tennessee (183)
Texas (1871)
United States (42779)
Utah (355)
Vermont (1)
Virginia (300)
Washington D.C. (88)
Washington State (994)
West Virginia (4)
Wisconsin (136)
Wyoming (2)
871,858 Results for "'".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Compass Pathways Announces Pricing of $150 Million Public Offering
February 18, 2026
·
7 min read
Press Releases
Aptar to Participate in Upcoming Investor Conferences - February 18, 2026
February 18, 2026
·
1 min read
Press Releases
ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM
February 18, 2026
·
8 min read
Press Releases
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call
February 18, 2026
·
1 min read
Press Releases
IQVIA to Speak at Citi’s 2026 Unplugged MedTech and Life Sciences Access Day
February 18, 2026
·
2 min read
Press Releases
Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 18, 2026
February 18, 2026
·
1 min read
Press Releases
Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2025 Financial Results and Host Conference Call on February 25, 2026
February 18, 2026
·
1 min read
Press Releases
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
February 18, 2026
·
2 min read
Press Releases
ACTG Announces Publication of LATITUDE Findings in the New England Journal of Medicine
February 18, 2026
·
5 min read
Press Releases
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
February 18, 2026
·
6 min read
1 of 87,186
Next
